ReviewJournal for immunotherapy of cancer2020

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy.

Christopher A Chuckran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.